Anti-inflammatory therapy in cystic fibrosis
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 4, 45-48
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: Influence of treatment with dornase alphaPediatric Pulmonology, 2004
- Azithromycin for cystic fibrosisEuropean Respiratory Journal, 2004
- Anti-inflammatory effects of montelukast in mild cystic fibrosisAnnals of Allergy, Asthma & Immunology, 2002
- Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trialThorax, 2002
- Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic Bronchopulmonary Pseudomonas aeruginosa InfectionAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosisBMJ, 1995
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosisRespiratory Medicine, 1995
- ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSISThe Lancet, 1985
- CHRONIC PSEUDOMONAS AERUGINOSA LUNG INFECTION IN CYSTIC FIBROSISActa Paediatrica, 1983